Loading clinical trials...
Loading clinical trials...
A Pilot Clinical Trial Combining PD-1 Blockade, CD137 Agonism and Adoptive Cell Therapy for Metastatic Melanoma
Conditions
Interventions
Nivolumab
Surgery to Remove Tumor for Growth of TIL
+5 more
Locations
1
United States
H. Lee Moffitt Cancer Center and Research Institute
Tampa, Florida, United States
Start Date
March 8, 2016
Primary Completion Date
August 30, 2020
Completion Date
August 30, 2020
Last Updated
August 19, 2025
NCT05047094
NCT07349940
NCT05702398
NCT07287917
NCT06956690
NCT07410676
Lead Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions